Overall, KLS positive and bulk bone marrow cells from ENU-induced AML and MDS mouse models were capable of establishing secondary transplants, but did not lead to rapidly fatal disease or recapitulation of the primary disease phenotype. This evidence concerns the gene RPS6KB2 and acute myeloid leukemia.